Market Reactions Eli Lilly Investor Sentiment Company Performance Eli Lilly Stock Sarepta Therapeutics Stock Vaccine Developers Novo Nordisk Stock Performance Novo Nordisk Shares Eli Lilly Stock Performance
Final USFDA clearance for two vial strengths boosts Alembic’s generics portfolio to 224 approvals, underscoring its expansion in injectable oncology drugs